Details for Patent: 7,709,493
Which drugs does patent 7,709,493 protect, and when does it expire?
Patent 7,709,493 protects XERMELO and is included in one NDA.
This patent has forty-one patent family members in twenty-four countries.
Summary for Patent: 7,709,493
| Title: | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
| Abstract: | Compounds of formula I are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and/or manage diseases and disorders: |
| Inventor(s): | Arokiasamy Devasagayaraj, Haihong Jin, Zhi-Cai Shi, Ashok Tunoori, Ying Wang, Chengmin Zhang |
| Assignee: | Tersera Therapeutics LLC |
| Application Number: | US12/468,974 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 7,709,493
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera | XERMELO | telotristat etiprate | TABLET;ORAL | 208794-001 | Feb 28, 2017 | RX | Yes | Yes | 7,709,493 | ⤷ Start Trial | Y | THE TREATMENT OF CARCINOID SYNDROME DIARRHEA IN COMBINATION WITH SOMATOSTATIN ANALOG (SSA) THERAPY IN ADULTS INADEQUATELY CONTROLLED BY SSA THERAPY | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,709,493
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2091940 | ⤷ Start Trial | CA 2018 00011 | Denmark | ⤷ Start Trial |
| European Patent Office | 2091940 | ⤷ Start Trial | 300929 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2091940 | ⤷ Start Trial | 122018000025 | Germany | ⤷ Start Trial |
| European Patent Office | 2091940 | ⤷ Start Trial | 2018C/009 | Belgium | ⤷ Start Trial |
| European Patent Office | 2091940 | ⤷ Start Trial | 1890014-2 | Sweden | ⤷ Start Trial |
| European Patent Office | 2091940 | ⤷ Start Trial | C201830016 | Spain | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
